Once daily dosing of 3g mesalamaine (Salofalk (R) granules) is therapeutic equivalent to a three-times daily dosing of 1g mesalamine for the treatment of active ulcerative colitis

W Kruis; A Gorelov; G Kiudelis; I Racz; J Pokrotnieks; M Horynski; M Batovsky; J Kykal; D Keret; R Greinwald; R Mueller

Once daily dosing of 3g mesalamaine (Salofalk (R) granules) is therapeutic equivalent to a three-times daily dosing of 1g mesalamine for the treatment of active ulcerative colitis

W Kruis, A Gorelov, G Kiudelis, I Racz, J Pokrotnieks, M Horynski, M Batovsky, J Kykal, D Keret, R Greinwald, R Mueller

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	898
Pages (from-to)	A130-A131
Journal	Gastroenterology
Volume	132
Issue number	4, Suppl.2
Publication status	Published - Apr 2007
Externally published	Yes
Event	Meeting of the American Society for Gastrointestinal Endoscopy (ASGE) "Digestive Disease Week" - Washington, United States Duration: 19 May 2007 → 24 May 2007

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Access to Document

https://www.gastrojournal.org/issue/S0016-5085(07)X6001-3

Cite this

Kruis, W., Gorelov, A., Kiudelis, G., Racz, I., Pokrotnieks, J., Horynski, M., Batovsky, M., Kykal, J., Keret, D., Greinwald, R., & Mueller, R. (2007). Once daily dosing of 3g mesalamaine (Salofalk (R) granules) is therapeutic equivalent to a three-times daily dosing of 1g mesalamine for the treatment of active ulcerative colitis. Gastroenterology, 132(4, Suppl.2), A130-A131. Article 898. https://www.gastrojournal.org/issue/S0016-5085(07)X6001-3

@article{8e8640e09afb470aa43cc6480cc07b61,

title = "Once daily dosing of 3g mesalamaine (Salofalk (R) granules) is therapeutic equivalent to a three-times daily dosing of 1g mesalamine for the treatment of active ulcerative colitis",

author = "W Kruis and A Gorelov and G Kiudelis and I Racz and J Pokrotnieks and M Horynski and M Batovsky and J Kykal and D Keret and R Greinwald and R Mueller",

year = "2007",

month = apr,

language = "English",

volume = "132",

pages = "A130--A131",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders Ltd",

number = "4, Suppl.2",

note = "Meeting of the American Society for Gastrointestinal Endoscopy (ASGE) {"}Digestive Disease Week{"}, DDW ; Conference date: 19-05-2007 Through 24-05-2007",

}

Kruis, W, Gorelov, A, Kiudelis, G, Racz, I, Pokrotnieks, J, Horynski, M, Batovsky, M, Kykal, J, Keret, D, Greinwald, R & Mueller, R 2007, 'Once daily dosing of 3g mesalamaine (Salofalk (R) granules) is therapeutic equivalent to a three-times daily dosing of 1g mesalamine for the treatment of active ulcerative colitis', Gastroenterology, vol. 132, no. 4, Suppl.2, 898, pp. A130-A131. <https://www.gastrojournal.org/issue/S0016-5085(07)X6001-3>

Once daily dosing of 3g mesalamaine (Salofalk (R) granules) is therapeutic equivalent to a three-times daily dosing of 1g mesalamine for the treatment of active ulcerative colitis. / Kruis, W; Gorelov, A; Kiudelis, G et al.
In: Gastroenterology, Vol. 132, No. 4, Suppl.2, 898, 04.2007, p. A130-A131.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Once daily dosing of 3g mesalamaine (Salofalk (R) granules) is therapeutic equivalent to a three-times daily dosing of 1g mesalamine for the treatment of active ulcerative colitis

AU - Kruis, W

AU - Gorelov, A

AU - Kiudelis, G

AU - Racz, I

AU - Pokrotnieks, J

AU - Horynski, M

AU - Batovsky, M

AU - Kykal, J

AU - Keret, D

AU - Greinwald, R

AU - Mueller, R

PY - 2007/4

Y1 - 2007/4

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=rsu_pure_&SrcAuth=WosAPI&KeyUT=WOS:000245927601157&DestLinkType=FullRecord&DestApp=WOS

UR - https://www-webofscience-com.db.rsu.lv/wos/alldb/full-record/WOS:000245927601157

M3 - Meeting Abstract

SN - 0016-5085

VL - 132

SP - A130-A131

JO - Gastroenterology

JF - Gastroenterology

IS - 4, Suppl.2

M1 - 898

T2 - Meeting of the American Society for Gastrointestinal Endoscopy (ASGE) "Digestive Disease Week"

Y2 - 19 May 2007 through 24 May 2007

ER -

Once daily dosing of 3g mesalamaine (Salofalk (R) granules) is therapeutic equivalent to a three-times daily dosing of 1g mesalamine for the treatment of active ulcerative colitis

Field of Science*

Publication Type*

Access to Document

Other files and links

Cite this